SERPINE2, an inhibitor of plasminogen activators, is highly expressed in the human endometrium during the secretory phase

Reproductive Biology and Endocrinology

Volumn 9, Issue , 2011, Pages

  Lee, Robert K ^a,b   Fan, Chi Chen ^a,c   Hwu, Yuh Ming ^a,d   Lu, Chung Hao ^a   Lin, Ming Huei ^a,d   Chen, Ying Jie ^a   Li, Sheng Hsiang ^a,d,e  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c YUANPEI UNIVERSITY   (Taiwan)

^d NURSING AND MANAGEMENT COLLEGE   (Taiwan)

^e NATIONAL TAIPEI UNIVERSITY OF TECHNOLOGY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMINOGEN ACTIVATOR; PROTEIN; SERINE PROTEINASE INHIBITOR; SERPINB2 PROTEIN; SERPINE1 PROTEIN; SERPINE2 PROTEIN; UNCLASSIFIED DRUG; PROTEASE NEXIN I; SERPINE2 PROTEIN, HUMAN;

ARTICLE; CLINICAL ARTICLE; ENDOMETRIUM BIOPSY; FEMALE; HUMAN; HUMAN TISSUE; HYSTERECTOMY; IMMUNOHISTOCHEMISTRY; MENSTRUAL CYCLE; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; UTERUS FLUID; WESTERN BLOTTING; BIOSYNTHESIS; BODY FLUID; CHEMISTRY; ENDOMETRIUM; LUTEAL PHASE; METABOLISM; UTERUS;

BODY FLUIDS; ENDOMETRIUM; FEMALE; HUMANS; LUTEAL PHASE; SERPIN E2; UTERUS;

EID: 79953100974     PISSN: None     EISSN: 14777827     Source Type: Journal    
DOI: 10.1186/1477-7827-9-38     Document Type: Article

References (27)

1. Vassalli JD, Sappino AP, Belin D. The plasminogen activator/plasmin system. J Clin Invest 1991, 88(4):1067-1072. 10.1172/JCI115405, 295552, 1833420.
2. Ebisch IM, Thomas CM, Wetzels AM, Willemsen WN, Sweep FC, Steegers-Theunissen RP. Review of the role of the plasminogen activator system and vascular endothelial growth factor in subfertility. Fertil Steril 2008, 90(6):2340-2350. 10.1016/j.fertnstert.2007.10.026, 18249395.
3. Saksela O, Rifkin DB. Cell-associated plasminogen activation: regulation and physiological functions. Annu Rev Cell Biol 1988, 4:93-126. 10.1146/annurev.cb.04.110188.000521, 3143380.
4. Casslen B, Astedt B. Fibrinolytic activity of human uterine fluid. Acta Obstet Gynecol Scand 1981, 60(1):55-58. 10.3109/00016348109154110, 7211236.
5. Casslen B, Astedt B. Occurrence of both urokinase and tissue plasminogen activator in the human endometrium. Contraception 1983, 28(6):553-564. 10.1016/0010-7824(83)90106-3, 6687051.
6. Koh SC, Wong PC, Yuen R, Chua SE, Ng BL, Ratnam SS. Concentration of plasminogen activators and inhibitor in the human endometrium at different phases of the menstrual cycle. J Reprod Fertil 1992, 96(2):407-413. 10.1530/jrf.0.0960407, 1339823.
7. Nordengren J, Pilka R, Noskova V, Ehinger A, Domanski H, Andersson C, Hoyer-Hansen G, Hansson SR, Casslen B. Differential localization and expression of urokinase plasminogen activator (uPA), its receptor (uPAR), and its inhibitor (PAI-1) mRNA and protein in endometrial tissue during the menstrual cycle. Mol Hum Reprod 2004, 10(9):655-663. 10.1093/molehr/gah081, 15243126.
8. Nordstrom L, Casslen B, Lecander I. Plasminogen activator inhibitor 2 in menstrual endometrium and in primary cultures of endometrial cells. Fibrinolysis 1996, 10(5-6):295-302.
9. Svanberg L, Astedt B. Release of plasminogen activator from normal and neoplastic endometrium. Experientia 1979, 35(6):818-819. 10.1007/BF01968271, 467604.
10. Hofmann GE, Glatstein I, Schatz F, Heller D, Deligdisch L. Immunohistochemical localization of urokinase-type plasminogen activator and the plasminogen activator inhibitors 1 and 2 in early human implantation sites. Am J Obstet Gynecol 1994, 170(2):671-676.
11. Teesalu T, Blasi F, Talarico D. Embryo implantation in mouse: fetomaternal coordination in the pattern of expression of uPA, uPAR, PAI-1 and alpha 2MR/LRP genes. Mech Dev 1996, 56(1-2):103-116. 10.1016/0925-4773(96)00515-1, 8798151.
12. Scott RW, Bergman BL, Bajpai A, Hersh RT, Rodriguez H, Jones BN, Barreda C, Watts S, Baker JB. Protease nexin. Properties and a modified purification procedure. J Biol Chem 1985, 260(11):7029-7034.
13. Chen LM, Skinner ML, Kauffman SW, Chao J, Chao L, Thaler CD, Chai KX. Prostasin is a glycosylphosphatidylinositol-anchored active serine protease. J Biol Chem 2001, 276(24):21434-21442. 10.1074/jbc.M011423200, 11274175.
14. Vassalli JD, Huarte J, Bosco D, Sappino AP, Sappino N, Velardi A, Wohlwend A, Erno H, Monard D, Belin D. Protease-nexin I as an androgen-dependent secretory product of the murine seminal vesicle. EMBO J 1993, 12(5):1871-1878. 413407, 8491179.
15. Lin HY, Zhang H, Yang Q, Wang HX, Wang HM, Chai KX, Chen LM, Zhu C. Expression of prostasin and protease nexin-1 in rhesus monkey (Macaca mulatta) endometrium and placenta during early pregnancy. J Histochem Cytochem 2006, 54(10):1139-1147. 10.1369/jhc.6A7005.2006, 16801525.
16. Kim NK, Choi MJ, Chung HM, Sohn TJ, Hwang SG, Oh D, Lee HH, Lee YH, Ko JJ. Increased expression and localization of a serine protease inhibitor, protease nexin-1 (PN-1), in the ovary and uterus during implantation in rat. Thromb Res 2001, 103(2):135-142. 10.1016/S0049-3848(01)00288-2, 11457471.
17. Chern SR, Li SH, Lu CH, Chen EI. Spatiotemporal expression of the serine protease inhibitor, SERPINE2, in the mouse placenta and uterus during the estrous cycle, pregnancy, and lactation. Reprod Biol Endocrinol 2010, 8:127. 10.1186/1477-7827-8-127, 2987947, 20977773.
18. Noyes RW, Hertig AT, Rock J. Dating the endometrial biopsy. Am J Obstet Gynecol 1975, 122(2):262-263.
19. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979, 76(9):4350-4354. 10.1073/pnas.76.9.4350, 411572, 388439.
20. Lu CH, Lee RK, Hwu YM, Chu SL, Chen YJ, Chang WC, Lin SP, Li SH. SERPINE2, a Serine Protease Inhibitor Extensively Expressed in Adult Male Mouse Reproductive Tissues, May Serve as a Murine Sperm Decapacitation Factor. Biol Reprod 2011, 84(3):514-525. 10.1095/biolreprod.110.085100, 21084713.
21. Howard EW, Knauer DJ. Characterization of the receptor for protease nexin-I:protease complexes on human fibroblasts. J Cell Physiol 1987, 131(2):276-283. 10.1002/jcp.1041310219, 3034924.
22. Wagner SL, Lau AL, Cunningham DD. Binding of protease nexin-1 to the fibroblast surface alters its target proteinase specificity. J Biol Chem 1989, 264(1):611-615.
23. Bouton MC, Venisse L, Richard B, Pouzet C, Arocas V, Jandrot-Perrus M. Protease nexin-1 interacts with thrombomodulin and modulates its anticoagulant effect. Circ Res 2007, 100(8):1174-1181. 10.1161/01.RES.0000265066.92923.ee, 17379830.
24. Salamonsen LA. Role of proteases in implantation. Rev Reprod 1999, 4(1):11-22. 10.1530/ror.0.0040011, 10051098.
25. Bédard J, Brule S, Price CA, Silversides DW, Lussier JG. Serine protease inhibitor-E2 (SERPINE2) is differentially expressed in granulosa cells of dominant follicle in cattle. Mol Reprod Dev 2003, 64(2):152-165.
26. Fayad T, Levesque V, Sirois J, Silversides DW, Lussier JG. Gene expression profiling of differentially expressed genes in granulosa cells of bovine dominant follicles using suppression subtractive hybridization. Biol Reprod 2004, 70(2):523-533. 10.1095/biolreprod.103.021709, 14568916.
27. Hagglund AC, Ny A, Liu K, Ny T. Coordinated and cell-specific induction of both physiological plasminogen activators creates functionally redundant mechanisms for plasmin formation during ovulation. Endocrinology 1996, 137(12):5671-5677. 10.1210/en.137.12.5671, 8940398.